Tirzepatide. Dual GLP-1/GIP receptor agonist, Treatment of type 2 diabetes and obesityT.L. Jensen,A. Bronden,K. Karstoft,D.P. Sonne,M.B. ChristensenDrugs of the Future(2023)引用 0|浏览3暂无评分关键词glp-1/gip receptor agonist,diabetes,obesityAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要